Ropes Wealth Advisors LLC Atara Biotherapeutics, Inc. Transaction History

Ropes Wealth Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$14.0 - $20.72 $10,136 - $15,001	-724 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$12.67 - $26.23 $4,586 - $9,495	362 Added 100.0%	724 $14,000
Q2 2020 Jul 20, 2020	BUY	$7.53 - $14.93 $2,725 - $5,404	362 New	362 $5,000
Q1 2019 Apr 15, 2019	SELL	$28.4 - $41.74 $10,280 - $15,109	-362 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$30.9 - $42.97 $11,185 - $15,555	362 New	362 $13,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $710M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Ropes Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Ropes Wealth Advisors LLC with notifications on news.